NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

What symbol and exchange does Neogenomics shares trade?

Neogenomics trades on the NASDAQ stock market under the symbol NEO.

What is Neogenomics stock price doing today?

As of October 16, 2026, NEO stock price declined to $16.65 with 1,860,229 million shares trading.

What is Neogenomics's Beta?

NEO has a beta of 0.54, meaning it tends to be less sensitive to market movements. NEO has a correlation of 0.01 to the broad based SPY ETF.

How much is Neogenomics worth?

NEO has a market cap of $2.14 billion. This is considered a Mid Cap stock.

How much money does Neogenomics make?

Last quarter Neogenomics reported $202 million in Revenue and $.05 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.04.

What is the highest and lowest price Neogenomics traded in the last 3 year period?

In the last 3 years, NEO traded as high as $21.22 and as low as $4.72.

What are the top ETFs holding Neogenomics?

The top ETF exchange traded funds that NEO belongs to (by Net Assets): IJR, FBT, VTI, IWM, VB.

Is Neogenomics (NEO) a good investment?

NEO has outperformed the market in the last year with a return of +62.0%, while the SPY ETF gained +16.7%. In the last 3 month period, NEO beat the market returning +12.2%, while SPY returned +1.9%. However, in the most recent 2 weeks NEO has underperformed the stock market by returning -9.9%, while SPY returned -0.8%.

What are the support and resistance levels for Neogenomics (NEO)?

NEO support price is $16.68 and resistance is $17.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NEO shares will trade within this expected range on the day.